Oct 19, 2021Best Practices When Implementing a Global Transparency ProgramBest Practices When Implementing a Global Transparency Program Each region across the globe has its own regional or local legal requirements regarding transparency reporting for healthcare professionals (HCPs). For example, the U.S. …Life Science4 min readLife Science4 min read
Jun 8, 2021CRM for CGT should be PRMCRM for CGT should be PRM In a recent blog post [1], we addressed the peculiarities of a CRM system dedicated to CGT. We summarized the needed changes in 5 dimensions from the data sources of the various stakeholders to the involvement of the physicians in the end to end…Cell And Gene Therapy4 min readCell And Gene Therapy4 min read
May 27, 2021Crucial CRM needs in the context of Cell and Gene TherapiesCrucial CRM needs in the context of Cell and Gene Therapies As more and more companies have embraced cell and gene therapies (CGT) to cure disease, it becomes evident that a standard commercial excellence approach is not fitting the needs of those new business models. The traditional CRM represents this…Cell And Gene Therapy4 min readCell And Gene Therapy4 min read
Apr 15, 2021Some trends in life science CRM for the remainder of 2021Some trends in life science CRM for the remainder of 2021 The last months have created multiple shocks in the way life sciences companies have engaged with HCPs in their respective areas. Companies have, of course, rushed on enabling remote detailing, but this was just one short-term response. At BASE…CRM6 min readCRM6 min read
Apr 7, 2021Content, channel & consents — the 3 C’s of a successful commercial launch in a pandemic and beyondContent, channel & consent — the 3 C’s of a successful commercial launch in a pandemic and beyond The COVID pandemic has been proven to slow down the pace of research in the life science industry. While some innovations have emerged, non-COVID-related research suffered from a redirection of resources[1]. This…Consent5 min readConsent5 min read
Jan 26, 2021Retain your competitive edge by following these 3 simple steps to optimize your consent strategyRetain your competitive edge by following these 3 simple steps to optimize your consent strategy In 2020 life science’s commercial operations have undergone rapid change. While all sales reps were stuck at home due to the various lockdown measures, the marketing teams and the commercial strategists have tried to reach…5 min read5 min read
Jan 19, 2021The unbeatable duo: artificial intelligence does not replace human intelligenceArtificial intelligence in the customer engagement area of pharmaceutical companies has been a buzz word for the last decade or so. However, after years of disruptive developments and multiple hopeful implementations, suggestions for the reps have failed to deliver on their promises, causing project failure within many companies. …5 min read5 min read
Dec 9, 2020Expanding the usage of your document management systemExpanding the usage of your document management system The medical and legal review process is unique to the life science industry. While operating in Europe, it is often a requirement that promotional material is reviewed and formally approved before publication. In some countries, the material must even be submitted to…3 min read3 min read
Sep 20, 2020A call for a new operating model for Commercial Operations in PharmaCovid-19 has impacted us all and will keep affecting our lives for the foreseeable future. At BASE, we were lucky enough to be able to keep doing what we love to do, supporting our life science clients to reach their customers. The latest months were exciting in that regard as…5 min read5 min read
Jul 22, 2020Regulatory Intelligence — focus on system and business process improvementsIn my recent post (link), I defined Regulatory Intelligence (RI) and described roles and tasks related to it. This blog post has been dedicated to dive deeper into reflections on the importance of the RI system and the related business processes, and how to improve these. Having a RI system…5 min read5 min read
